BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 778618)

  • 1. Drug therapy. Hydralazine.
    Koch-Weser J
    N Engl J Med; 1976 Aug; 295(6):320-3. PubMed ID: 778618
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator drugs in the treatment of hypertension.
    Koch-Weser J
    Arch Intern Med; 1974 Jun; 133(6):1017-27. PubMed ID: 4597950
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Hydralazine therapy in idiopathic SLE.
    Hess EV; Litwin A; Foad BS
    Arthritis Rheum; 1976; 19(1):122-3. PubMed ID: 1082750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with the combination of beta receptor blockader and hydralazine in the treatment of hypertension].
    Jensen HE; Rasmussen K
    Ugeskr Laeger; 1976 Mar; 138(14):860-3. PubMed ID: 772901
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
    Cotton DB; Gonik B; Dorman KF
    Surg Gynecol Obstet; 1985 Sep; 161(3):240-4. PubMed ID: 4035539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 8. Individualization of antihypertensive drug therapy.
    Koch-Weser J
    Med Clin North Am; 1974 Sep; 58(5):1027-36. PubMed ID: 4609362
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.
    Brunner H; Hedwall PR; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):123-33. PubMed ID: 6039968
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine-induced lupus erythematosus-like syndrome.
    Irias JJ
    Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of primary hypertension. 2.
    Page LB; Sidd JJ
    N Engl J Med; 1972 Nov; 287(20):1018-23. PubMed ID: 4568395
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus.
    Reza MJ; Dornfeld L; Goldberg LS
    Arthritis Rheum; 1975; 18(4):335-8. PubMed ID: 50845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocking therapy: Propranolol.
    Pettinger WA
    Postgrad Med; 1974 Oct; 56(5):68-73. PubMed ID: 4412183
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced lupus: clinical and serological studies.
    Harmon CE; Portanova JP
    Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
    Kronzon I; Cohen M; Winer HE
    JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydralazine antinuclear antibodies and the lupus syndrome.
    Ramsay LE; Silas J; Freestone S
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1711. PubMed ID: 6805676
    [No Abstract]   [Full Text] [Related]  

  • 20. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
    Perry HM
    Am J Med; 1973 Jan; 54(1):58-72. PubMed ID: 4581906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.